DSIP
L-tryptophyl-L-alanyl-glycyl-glycyl-L-aspartyl-L-alanyl-L-seryl-glycyl-L-glutamic acid
DSIP is a naturally occurring nonapeptide identified in 1977 from rabbit cerebral venous blood, comprising nine amino acids in the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. This linear, hydrophilic peptide maintains its endogenous structure without synthetic modifications, making it ideal for sleep regulation research, stress response modulation, and central nervous system function studies in controlled experimental settings.
Complete Dosing Guide
Special Considerations
Age Factors:
- No specific dose adjustments needed for older adults
- Monitor for enhanced sensitivity to effects
Gender Considerations:
- No gender-specific dosing requirements identified
- Standard protocols apply to both males and females
Combination with Other Peptides:
- Can be combined with other sleep-supporting peptides
- Avoid concurrent use with opioid antagonists (e.g., Naloxone)
Tolerance Development:
- Some users report diminishing effects with continuous use
- Cycling recommended to maintain efficacy
Medical Disclaimer
DSIP is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Any use should occur only under medical supervision in approved research settings.